Gérard Ber

Gérard Ber

Director/Board Member at LANTHEUS HOLDINGS, INC.

Net worth: 3 M $ as of 31/05/2026

68 year
Health Technology
Consumer Services
Commercial Services

Profile

Gérard Ber was the founder of Advanced Accelerator Applications SA, founded in 2002, serving as Chief Operating Officer from 2014 to 2018.
Current jobs include Director at Lantheus Medical Imaging, Inc. since 2020, Independent Director at Lantheus Holdings, Inc. since 2020, Director at Advanced Accelerator Applications (UK & Ireland) Ltd., Independent Director at CUTISS AG since 2020, and Director at Evergreen Theragnostics, Inc. Former jobs include Independent Director at Progenics Pharmaceuticals, Inc. from 2019 to 2020, Director General at CIS Bio International SA, Director-Marketing & Sales Western Europe at OM Pharma SA, and Independent Director at Y-mAbs Therapeutics, Inc. from 2018 to 2024.
Education includes graduate and doctorate degrees from Université Joseph Fourier, both conferred in 1984, and an undergraduate degree from Institut de Pharmacie Industrielle de Paris, conferred in 1984.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
14/05/2026 27,118 ( 0.04% ) 3 M $ 31/05/2026

Gérard Ber active positions

CompaniesPositionStart
LANTHEUS HOLDINGS, INC. Director/Board Member 19/06/2020
Director/Board Member -
Director/Board Member -
Director/Board Member 01/06/2020
Director/Board Member 28/05/2020

Former positions of Gérard Ber

CompaniesPositionEnd
YMAS THER Director/Board Member 10/06/2024
PROGENICS PHARMACEUTICALS, INC. Director/Board Member 19/06/2020
ADVANCED ACCELERATOR APPLICATION SA(ADR) Founder 01/01/2018
Sales & Marketing -
░░░ ░░░ ░░░░░░░░░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
See the detail of Gérard Ber's experience

Training of Gérard Ber

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

45

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!